Log In
Print this Print this

hydrocodone bitartrate ER, Vantrela ER (CEP-33237)

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionTwice-daily, acetaminophen-free hydrocodone bitartrate extended-release (ER) tablets formulated with an abuse-deterrent technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard IndicationPain
Indication DetailsTreat chronic pain; Treat moderate to severe chronic low back; Treat moderate to severe pain in patients with osteoarthritis or low back pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today